Hospital
Frisbie Memorial Hospital
Frisbie Memorial Hospital was paid $4.80M by Medicaid between Jan 2018 and May 2020, across 186 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoFRISBIE MEMORIAL HOSPITAL
ROCHESTER, NH 03867
ROCHESTER, NH 03867
33aNPI1003858408assigned 06/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.80M
24GClaims220,772
24DCodes billed186
24AFirst – last monthJan 2018 – May 2020
Compared with peers
Next to other General Acute Care Hospital providers in New Hampshire
Rank by total paid#7 of 9
Median peer was paid$10.80M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 101,600 | $1.98M | |
| 2019 | 101,751 | $2.39M | |
| 2020 | 17,421 | $433K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 15,560 | 9,788 | $762K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 8,943 | 5,646 | $735K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 2,662 | 1,675 | $305K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 6,629 | 4,873 | $252K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.1% | 973 | 757 | $244K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 4.0% | 2,937 | 1,563 | $194K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.9% | 1,155 | 854 | $189K |
| 71046 | Radiologic examination, chest; 2 views | 3.1% | 4,396 | 3,360 | $151K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 2,907 | 2,135 | $119K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.4% | 16,345 | 8,412 | $116K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.2% | 2,212 | 745 | $106K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.1% | 1,477 | 842 | $101K |
174 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 3,454 | $61K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 284 | $60K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 1,688 | $57K |
| 80053 | Comprehensive metabolic panel | 1.1% | 11,417 | $54K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.1% | 593 | $54K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 1,641 | $52K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,878 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,501 | $41K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,532 | $41K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 446 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,313 | $36K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,311 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,242 | $34K |
| 76830 | Ultrasound, transvaginal | <1% | 358 | $34K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 603 | $32K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,204 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,535 | $30K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,100 | $26K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,019 | $26K |
| A0425 | Ground mileage, per statute mile | <1% | 4,637 | $24K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 554 | $22K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 235 | $21K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 439 | $21K |
| 99000 | <1% | 8,647 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,465 | $21K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 81 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,025 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,025 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,351 | $17K |
| 80061 | Lipid panel | <1% | 1,896 | $16K |
| 73610 | <1% | 364 | $16K | |
| 76801 | <1% | 183 | $15K | |
| 73130 | <1% | 353 | $15K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 502 | $15K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 108 | $15K |
| 73630 | <1% | 394 | $15K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 110 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 737 | $14K |
| 71045 | Radiologic examination, chest; single view | <1% | 934 | $14K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 63 | $14K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 557 | $12K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 414 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 634 | $12K |
| 76820 | <1% | 239 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,924 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,672 | $10K |
| 87077 | <1% | 1,574 | $10K | |
| 97597 | <1% | 234 | $10K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 623 | $9K |
| 73030 | <1% | 228 | $9K | |
| 71250 | <1% | 95 | $8K | |
| 73110 | <1% | 246 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 253 | $7K |
| G0378 | Hospital observation service, per hour | <1% | 112 | $7K |
| 72100 | <1% | 182 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 846 | $7K |
| 84484 | <1% | 2,114 | $6K | |
| 87040 | <1% | 1,480 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,496 | $6K |
| 97162 | <1% | 248 | $6K | |
| 84702 | <1% | 639 | $6K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 35 | $6K |
| 73564 | <1% | 133 | $6K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 622 | $5K |
| 93971 | <1% | 63 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 57 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 141 | $5K |
| 85027 | <1% | 1,786 | $5K | |
| 87081 | <1% | 1,119 | $5K | |
| 83690 | <1% | 1,439 | $5K | |
| 82550 | <1% | 2,240 | $5K | |
| 87186 | <1% | 1,003 | $5K | |
| 86850 | <1% | 593 | $5K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,255 | $4K |
| 81001 | <1% | 2,678 | $4K | |
| 83735 | <1% | 1,690 | $4K | |
| 74018 | <1% | 178 | $4K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 506 | $4K |
| 97161 | <1% | 254 | $4K | |
| 82553 | <1% | 2,059 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,391 | $4K |
| 86803 | <1% | 395 | $4K | |
| 96376 | <1% | 282 | $3K | |
| 12001 | <1% | 55 | $3K | |
| 86780 | <1% | 356 | $3K | |
| 94060 | <1% | 66 | $3K | |
| 83880 | <1% | 351 | $3K | |
| 80050 | General health panel | <1% | 484 | $3K |
| 82607 | <1% | 383 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 928 | $3K |
| 82728 | <1% | 413 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 53 | $3K |
| 84439 | <1% | 450 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 27 | $3K |
| 83605 | <1% | 583 | $2K | |
| 85379 | <1% | 515 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 239 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 537 | $2K |
| 87340 | <1% | 337 | $2K | |
| 86140 | <1% | 655 | $2K | |
| 83550 | <1% | 452 | $2K | |
| 85610 | <1% | 1,310 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 162 | $2K |
| 83540 | <1% | 535 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,402 | $2K |
| 73140 | <1% | 49 | $2K | |
| 86618 | <1% | 165 | $1K | |
| 81025 | <1% | 378 | $1K | |
| 87150 | <1% | 77 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,285 | $1K |
| 81003 | <1% | 1,257 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,795 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 74 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 30 | $1K |
| 85652 | <1% | 701 | $1K | |
| 85007 | <1% | 1,121 | $1K | |
| 94729 | <1% | 50 | $1K | |
| 82746 | <1% | 119 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 370 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,445 | $835.82 |
| 87205 | <1% | 332 | $811.05 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 111 | $800.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,189 | $782.99 |
| 82043 | <1% | 239 | $773.53 | |
| 82570 | <1% | 259 | $755.12 | |
| 76770 | <1% | 24 | $722.52 | |
| 86906 | <1% | 111 | $602.13 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 367 | $565.36 |
| 87653 | <1% | 44 | $564.37 | |
| 80074 | <1% | 16 | $496.59 | |
| 73080 | <1% | 14 | $479.27 | |
| 97035 | <1% | 67 | $476.50 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 272 | $452.25 |
| 82784 | <1% | 51 | $404.28 | |
| 87140 | <1% | 100 | $394.67 | |
| 87808 | <1% | 33 | $368.32 | |
| 87905 | <1% | 37 | $366.10 | |
| 36416 | <1% | 708 | $334.79 | |
| 84100 | <1% | 292 | $333.75 | |
| 82948 | <1% | 537 | $322.09 | |
| 84403 | <1% | 14 | $299.28 | |
| 94726 | <1% | 13 | $293.66 | |
| 90715 | <1% | 49 | $282.93 | |
| G0008 | Administration of influenza virus vaccine | <1% | 422 | $244.52 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 241 | $235.54 |
| 86038 | <1% | 31 | $234.47 | |
| S9982 | Medical records copying fee, per page | <1% | 15 | $228.00 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 370 | $220.34 |
| 86762 | <1% | 20 | $212.33 | |
| 80076 | <1% | 42 | $207.43 | |
| 84146 | <1% | 16 | $207.01 | |
| 90662 | <1% | 117 | $199.70 | |
| 86900 | <1% | 111 | $180.06 | |
| 83655 | <1% | 15 | $157.50 | |
| 82950 | <1% | 46 | $153.68 | |
| 90686 | <1% | 251 | $131.87 | |
| 87210 | <1% | 65 | $131.45 | |
| 83516 | <1% | 15 | $129.25 | |
| 82565 | <1% | 63 | $121.69 | |
| 84481 | <1% | 13 | $117.68 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 36 | $80.72 |
| 85730 | <1% | 17 | $77.66 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 112 | $71.43 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 15 | $62.07 |
| 86431 | <1% | 14 | $49.30 | |
| 85378 | <1% | 15 | $39.45 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 47 | $38.55 |
| 84460 | <1% | 13 | $36.80 | |
| 84156 | <1% | 14 | $32.07 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 20 | $18.51 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 67 | $12.43 |
| A9270 | Non-covered item or service | <1% | 83 | $7.52 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 133 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAPLE, JOCELYN (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Frisbie Memorial Hospital | Rochester, NH | $1.24M |
| Salmon Falls Pathology LLC | Rochester, NH | $8K |
| Frisbie Memorial Hospital | Rochester, NH | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.